RLX Technology Q1 2026 Earnings EPS Miss Amid Margin Pressures CSR Q1 2026 Earnings EPS Misses Estimates Sharply Stock Gains on Strategic Outlook American Rebel Holdings Q1 2026 Earnings Negative EPS Highlights Ongoing Operational Headwinds ADC Therapeutics Q1 2026 Earnings EPS Beat but No Revenue Reported Stock Slips IRTC Q1 2026 Earnings Narrowing Losses Beat Expectations as Operating Discipline Drives Results Vera Therapeutics Q1 2026 Earnings EPS Miss Highlights PreRevenue Stage Challenges